Advertisement

Outpatient Spine

Mazor CEO Ori Hadomi mentioned in the 2017 earnings call earlier this week the company is pivoting efforts for its Renaissance robotic spine surgery system to target the ASC market, according to a transcript published in Seeking Alpha.

Advertisement
Advertisement